By Cara Bayles ( January 4, 2018, 9:02 PM EST) -- A California federal judge on Thursday denied Transposagen Biopharmaceuticals Inc.'s bid to dismiss a suit alleging it infringed Kyowa Hakko Kirin Co.'s patents for man-made antibodies, saying Transposagen should have made its improper venue arguments in May, after the U.S. Supreme Court's TC Heartland decision....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.